EPHX2 and neoplasm: Patients with high EPHX2 expression in 18 TCGA tumor types (ACC, BRCA, CESC, COAD, ESCA, HNSC, KIRC, LGG, LIHC, LUAD, MESO, PAAD, PRAD, READ, SARC, THCA, THYM, and UCEC) achieved lower TIDE scores compared with the low EPHX2 group (Figure 9).